LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Dasatinib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 989 | 4156 | 0.2380 | -0.0842 |
MCF7 | Dovitinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3441 | 4156 | 0.8279 | 0.7552 |
MCF7 | Enzastaurin | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4134 | 4156 | 0.9947 | 0.9924 |
MCF7 | Erlotinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3604 | 4156 | 0.8673 | 0.8112 |
MCF7 | Foretinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 1873 | 4156 | 0.4507 | 0.2183 |
MCF7 | R406 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4432 | 4156 | 1.0664 | 1.0944 |
MCF7 | Pictilisib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 1451 | 4156 | 0.3492 | 0.0739 |
MCF7 | Gefitinib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4513 | 4156 | 1.0859 | 1.1223 |
MCF7 | Geldanamycin | 0.12 | uM | LJP5 | 72 | hr | 1235 | 1560 | 4156 | 0.3754 | 0.1113 |
MCF7 | Geldanamycin | 0.12 | uM | LJP6 | 72 | hr | 1235 | 1539 | 4156 | 0.3703 | 0.1040 |
MCF7 | GSK1059615 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3935 | 4156 | 0.9468 | 0.9243 |
MCF7 | GSK1059615 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3305 | 4156 | 0.7953 | 0.7087 |
MCF7 | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 1235 | 1785 | 4156 | 0.4295 | 0.1882 |
MCF7 | Omipalisib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 1363 | 4156 | 0.3281 | 0.0439 |
MCF7 | GSK 690693 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 2213 | 4156 | 0.5325 | 0.3347 |
MCF7 | GW843682X | 0.12 | uM | LJP6 | 72 | hr | 1235 | 1616 | 4156 | 0.3889 | 0.1304 |
MCF7 | HG-5-113-01 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 2603 | 4156 | 0.6263 | 0.4682 |
MCF7 | HG-5-88-01 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 2639 | 4156 | 0.6351 | 0.4808 |
MCF7 | Imatinib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4463 | 4156 | 1.0738 | 1.1051 |
MCF7 | JNK-9L | 0.12 | uM | LJP6 | 72 | hr | 1235 | 2098 | 4156 | 0.5049 | 0.2955 |
MCF7 | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 2410 | 4156 | 0.5799 | 0.4023 |
MCF7 | Lapatinib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 3265 | 4156 | 0.7856 | 0.6949 |
MCF7 | LDN-193189 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4265 | 4156 | 1.0262 | 1.0373 |
MCF7 | Linifanib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 4619 | 4156 | 1.1114 | 1.1586 |
MCF7 | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3268 | 4156 | 0.7864 | 0.6960 |